Regional Communications

The following Regional Advisories and Memoranda have been issued by the Monroe-Livingston Regional Medical Director. Advisories that are obsolete or superseded are not posted here but are available through our office.

Questions, concerns, or suggestions for revision can be directed to mlrems@mlrems.org.

Obsolete and Rescinded Advisories

Advisory 23-08 Stroke and Associated Care Bundles
Advisory 23-07 Changes in MLREMS Preceptor Credentialing
Advisory 23-05 2022 CARES Data
Advisory 23-01 BLS iGel Demonstration Project
Advisory 22-09 Prehospital Trauma Notifications
Advisory 22-08 Access to Collaborative Protocols
Advisory 22-05 Extracorporeal Cardiac Life Support (ECLS) (Superseded by Advisory 24-03)
Advisory 22-03 RESCINDED EMS Geriatric Teleconsult Algorithm
Advisory 22-02 Alternative Transportation to the BHACC (Superseded by Advisory 25-01)
Advisory 21-14 Alternative Transportation to the BHACC (Superseded by Advisory 22-02)
Advisory 21-13 RESCINDED EMS Geriatric Teleconsult Algorithm
Advisory 21-12 NYS BEMSAT CME Submission Portal Training Update
Advisory 21-11 NYS BEMS CME Submission Portal Training
Advisory 21-06 Transferring Care to a Mental Health Team
Advisory 21-03 Updated Policies
Advisory 21-02 Communicating with the Culturally Deaf Patient
Advisory 21-01 Ketamine for Analgesia
Advisory 20-16 SNF-ALF Asymptomatic COVID Evaluation Algorithm
Advisory 20-14 Patient Refusal of Treatment/Transport Policy
Advisory 20-12 CME Allocation Matrix for Original Standardized Course Offerings (Superseded by Advisory 21-07)
Advisory 20-11 Emergency Incident Rehabilitation Policy
Advisory 20-10 RESCINDED Adult Cardiac Arrest Management Protocol
Advisory 20-08 Airway and Respiratory Management in COVID-19
Advisory 20-07 Termination of Resuscitation & Death Notification Training
Advisory 20-06 COVID Assessment Protocol
Advisory 20-05 COVID Care Guidelines
Advisory 20-04 COVID-19 Responder Exposure and Monitoring Update
Advisory 20-03 COVID-19 Update
Advisory 20-02 2019 Novel Coronavirus
Advisory 20-01 Phosphodiesterase Inhibitors and Nitrates
Advisory 19-10 Hospital Prenotification
Advisory 19-09A 2019 NYS EMS Collaborative Protocol Update
Advisory 19-09 NYS Protocol Update Interim Guidance (Superseded by Advisory 19-09A)
Advisory 19-08 Smoking on Hospital Grounds
Advisory 19-07 Patients Receiving Thrombolytics
Advisory 19-06 Mobile Stroke Unit – Regional Training
Advisory 19-05 Updated Care Bundles
Advisory 19-03 Syringe Epinephrine Update
Advisory 19-01 Updated Policy – On Scene Medical Personnel
Advisory 18-10 Ketorolac Dosing
Advisory 18-09 Changes in MLREMS Preceptor Credentialing
Advisory 18-06 Rapid Sequence Induction Quality Improvement Program
Advisory 18-04 Spinal Motion Restriction Training
Advisory 18-01 Updated Policies – RSI Policy, Performance Measures and Care Bundles
Advisory 17-09 St. Mary’s Psychiatric Emergency Center Closure
Advisory 17-05 Updated Policies
Advisory 17-04 Epinephrine Shortage
Advisory 17-03 Carfentanil
Advisory 17-01 Collaborative Protocols
Advisory 16-11 Unknown Patients
Advisory 16-09 Protocol Update
Advisory 16-08 Needle Thoracostomy (Superseded by Advisory 20-13)
Advisory 16-06 Hospital Medication Stations
Advisory 16-05 Response to Mass Trauma
Advisory 16-04 Improving Patient Handoffs EMS Providers
Advisory 16-03 Draft Collaborative Protocols
Advisory 16-02 BLS Preceptor Program
Advisory 16-01 New Prehospital Stroke Stickers
Advisory 15-15 Travel Screening for EVD
Advisory 15-14 Non-Invasive Positive Pressure Ventilation
Advisory 15-13 Spinal Motion Restriction
Advisory 15-12 Ondansetron for Pediatrics
Advisory 15-10 DOH TBI Wallet Cards
Advisory 15-09 NYS BLS Protocol Update
Advisory 15-08 Certification for Individuals with Criminal Convictions
Advisory 15-06 Change to Mandated Reporting
Advisory 15-05 BLS Medication Cards
Advisory 15-04 Stroke Notifications to Unity
Advisory 15-03 Measles
Advisory 15-02 Sepsis
Advisory 15-01 Updated EVD – Removal of Mali
Advisory 14-15 EVD Preparedness
Advisory 14-14 PPE
Advisory 14-13 Ebola Virus Disease Update
Advisory 14-12 Enterovirus
Advisory 14-11 Ebola Virus Disease
Advisory 14-10 Strong West
Advisory 14-09 Blood Glucometry
Advisory 14-08 Total Artificial Hearts
Advisory 14-07 Pediatric Ivs
Advisory 14-06 CME Recertification Policy
Advisory 14-05 MERS
Advisory 14-04 Normal Saline
Advisory 14-03 Charcoal
Advisory 14-02 2014 Protocols
Advisory 14-01 Ketamine
Advisory 13-14 BLS Naloxone
Advisory 13-13 Hydroxocobalamin
Advisory 13-12 ROSC and TH
Advisory 13-11 Trauma Triage Hospital Notifications
Advisory 13-10 Phenergan
Advisory 13-09 Methylprednisolone
Advisory 13-08 Rheos Devices
Advisory 13-07 Nausea/Vomiting Protocol Clarification
Advisory 13-06 King Airways
Advisory 13-05 Ultrasound Policy
Advisory 13-04 Stroke and STEMI Alert Patient Identifiers
Advisory 13-03 Management of Psychiatric & Violent or Potentially Violent Patients (Superseded by Advisory 21-03)
Advisory 13-02 Ventricular Assist Devices
Advisory 13-01 Point of Care Testing Policy
Advisory 12-07 BLS Medication Vodcasts
Advisory 12-06 EMS Week
Advisory 12-05 Safety Alert – Infusion Labeling
Advisory 12-05 Infusion Labeling – Updated Version
Advisory 12-03 2012 Protocol Update
Advisory 12-02 Epinephrine Auto-Injector Usage Reporting and Event Form
Advisory 12-01 CME Allocation Matrix for Original Standardized Course Offerings
Advisory 11-16 2012 Protocols and ALS Medication Requirements
Advisory 11-15 Fentanyl Substock Maximum
Advisory 11-14 Intermediate and Critical Care Scope of Practice
Advisory 11-13 Carrying Medications and Equipment
Advisory 11-12 Use of Orogastric Tubes
Advisory 11-11 Management of Pelvic Fractures
Advisory 11-10 Updated MLREMS Section 3 and 4 Protocols
Advisory 11-09 Life Threatening Hemorrhage Policy and Vodcasts
Advisory 11-08 ALS Provider Forms
Advisory 11-07 ALS Preceptor Policy
Advisory 11-06 Assuring Timely Response
Advisory 11-05 Pediatric Vodcasts
Advisory 11-04 Important Recall Notice
Advisory 11-03 Ventricular Assist Devices with Protocol Attached
Advisory 11-03 Ventricular Assist Devices
Advisory 11-02 DOH Policy 11-01 Blood Draws for Law Enforcement
Advisory 11-01 New AHA Guidelines
Advisory 10-19 Aspirin
Advisory 10-18 Regional Performance Measures (Superseded by Advisory 18-01)
Advisory 10-17 Mandated Child Abuse/Neglect Reporting
Advisory 10-16 New Return of Spontaneous Circulation Protocols 3.2 and 4.2
Advisory 10-15 Contacting Medical Control 2012 Revision
Advisory 10-15 Contacting Medical Control
Advisory 10-13 Substance Abuse Policies
Advisory 10-12 Bureau of EMS Policy 10-5 on DNR and MOLST
Advisory 10-11 Epinephrine 1:10,000 Shortage
Advisory 10-10 Midazolam Dosing
Advisory 10-08 ALS Monitor as AEDs
Advisory 10-07 Selective Spinal Update
Advisory 10-06 Code Red
Advisory 10-05 AED and Epi-Pen
Advisory 10-04 Controlled Substance Requirement for ALS Agencies
Advisory 10-03 Medication Removal for 2010 Protocol Change
Advisory 10-01 BEMS Policies 09-11, 13 and 10-1,2
Advisory 09-09 Protocols and BEMS Policy 09-10
Advisory 09-08 King Airway
Advisory 09-07 IV Tubing
Advisory 09-06 Equipment for Needle Chest Decompression (Superseded by Advisory 16-08)
Advisory 09-05 Social Networking
Advisory 09-04 QA/Computer Use
Advisory 09-03 Injury Reporting
Advisory 09-02 Controlled Substance Requirement
Advisory 09-01 Standards of Care
Advisory 08-05 Medication Lock Up
Advisory 08-04 Spinal Immobilization
Advisory 08-03 Atro-Pens
Advisory 08-02 Agency Medical Director Expectations
Advisory 07-11 Capnography Requirement
Advisory 07-10 Refusal Policy
Advisory 07-09 BG Monitoring
Advisory 07-07 HIPAA
Advisory 07-06 Pediatric Intubation
Advisory 07-03 Aspirin
Advisory 07-02 Activated Charcoal
Advisory 07-01 Diltiazem-Metoprolol
Advisory 06-01 Role of Agency Medical Director

Regional Communications

2025

2024

2023

2022

2021

2020 and Older

Obsolete and Rescinded Advisories

Mailing Address:

Office Address: